Form 4 for VTGN Vistagen Therapeutics, Inc.
Accepted 2021-09-08 00:00:00 ET · period of report 2021-09-07 · accession 0001415889-21-004287 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-08 | 2021-09-07 | VTGN | DOTSON JERROLD DUANE | VP, CFO AND Sec | S - Sale | $3.13 | -30.0K | 72.8K | -29% | -$93.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-07 | S | D | 30,000 | $3.13 | 72,786 | D | — | — |